176 related articles for article (PubMed ID: 29630134)
41.
Hollingshead C; Luttmann K; Abu Sitta E; Elsaghir H
BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32188621
[No Abstract] [Full Text] [Related]
42. Milkvetch root improves immune function in patients with acute exacerbation of COPD.
Jiang D; Wang X; Su Q; Jiang S; Yuan F; Zhang C; Gong F; Dong Q; Shi J; Chen B
Biomed Mater Eng; 2015; 26 Suppl 1():S2113-21. PubMed ID: 26405990
[TBL] [Abstract][Full Text] [Related]
43. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
44. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
45. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
46. Cavernoscopic Views of a Pleural Aspergillosis.
Ocak S; d'Odémont JP
Am J Respir Crit Care Med; 2021 Jan; 203(1):e1-e2. PubMed ID: 33021398
[No Abstract] [Full Text] [Related]
47. Rare diagnosis in a neonate who presents with fever.
Davoodi P; Wright SA; Brown EV; Perry JR
Clin Pediatr (Phila); 2015 Jan; 54(1):91-3. PubMed ID: 25022948
[No Abstract] [Full Text] [Related]
48. [Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
Grysczyk H; De Roux A; Grassot A; Mauch H; Lode H
Dtsch Med Wochenschr; 2002 Mar; 127(10):492-6. PubMed ID: 11884987
[TBL] [Abstract][Full Text] [Related]
49. Chronic cavitary pulmonary aspergillosis in an infant.
Liu Z; Qiao L; Li D; Yu L; Yi L
Lancet Infect Dis; 2021 Dec; 21(12):1757. PubMed ID: 34838236
[No Abstract] [Full Text] [Related]
50. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.
Bulpa P; Dive A; Sibille Y
Eur Respir J; 2007 Oct; 30(4):782-800. PubMed ID: 17906086
[TBL] [Abstract][Full Text] [Related]
51. Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives.
Alastruey-Izquierdo A; Cadranel J; Flick H; Godet C; Hennequin C; Hoenigl M; Kosmidis C; Lange C; Munteanu O; Page I; Salzer HJF;
Respiration; 2018; 96(2):159-170. PubMed ID: 29982245
[TBL] [Abstract][Full Text] [Related]
52. Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention.
Kaur R; Dennison SR; Burrow AJ; Rudramurthy SM; Swami R; Gorki V; Katare OP; Kaushik A; Singh B; Singh KK
J Nanobiotechnology; 2021 Jan; 19(1):19. PubMed ID: 33430888
[TBL] [Abstract][Full Text] [Related]
53. A Prospective Real-World Study of the Impact of an Antifungal Stewardship Program in a Tertiary Respiratory-Medicine Setting.
Nwankwo L; Periselneris J; Cheong J; Thompson K; Darby P; Leaver N; Schelenz S; Armstrong-James D
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012769
[TBL] [Abstract][Full Text] [Related]
54. [Mixed types of pulmonary aspergillosis].
Mu X; Yu J; Nie L; Cheng Y; Wang G
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Sep; 37(9):677-81. PubMed ID: 25533690
[TBL] [Abstract][Full Text] [Related]
55. Allergic Bronchopulmonary Mycosis Due to Schizophyllum commune Treated Effectively with Voriconazole.
Ishiguro T; Kagiyama N; Kojima A; Yamada M; Nakamoto Y; Takaku Y; Shimizu Y; Kurashima K; Takayanagi N
Intern Med; 2018 Sep; 57(17):2553-2557. PubMed ID: 29607966
[TBL] [Abstract][Full Text] [Related]
56. Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis.
Gao J; Zhang Q; Wu Y; Li Y; Qi T; Zhu C; Liu S; Yu R; He Q; Wen W; Zhou F; Chen Y; Chen J; Hou J
Sci Rep; 2018 Jan; 8(1):876. PubMed ID: 29343867
[TBL] [Abstract][Full Text] [Related]
57. [Evaluation of therapy efficiency in patients with combined course of copd and osteoarthritis].
Хайменова ГС; Шилкина ЛН; Бабанина МЮ; Волченко ГВ; Ткаченко МВ; Ждан ВН
Wiad Lek; 2016; 69(2 Pt 2):214-8. PubMed ID: 27487536
[TBL] [Abstract][Full Text] [Related]
58. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
59. [Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
Kiyokawa H; Nakashima R; Takafuji S; Suzuki Y; Ito A
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):448-54. PubMed ID: 18592989
[TBL] [Abstract][Full Text] [Related]
60. [A case of pulmonary aspergilloma successfully treated with transbronchial intracavitary itraconazole].
Tani S; Tomioka H; Tsuchimoto K; Kaneda T; Kubota M; Kaneko M; Fujii H
Nihon Kokyuki Gakkai Zasshi; 2008 Dec; 46(12):997-1002. PubMed ID: 19195200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
